Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Why is this work relevant for Creative Strategy? The challenge was how to break through the fading attention for long-missing children, whose cases often go unnoticed. By analysing data on public ...

At the University of Nevada, Reno, we believe in the power of purpose and the strength of the Pack. Whether you're engineering clean energy, studying literature’s role in social change, or designing ...

President Trump on Monday night announced tariffs of 10% on softwood timber and lumber alongside a 25% tariff on "certain upholstered wooden products" due to take effect on Oct. 14, according to the ...

AKREX - Akre Focus Retail - Review the AKREX stock price, growth, performance, sustainability and more to help you make the best investments.